IGF1 and hypopituitarism: Current guidelines suggest that retesting should be performed in all patients except in those with ≥ 3 pituitary hormone deficiencies and low-serum IGF-1 concentrations (<-2.0 SDS), those with genetic defects affecting the HP axis, and those with HP structural brain defects (35).